Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial
- 1 June 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 160 (6), 1308-1314
- https://doi.org/10.1111/j.1365-2133.2009.09119.x
Abstract
Photodynamic therapy (PDT) is an effective but time-consuming and often painful treatment for actinic keratosis (AK). Home-based daylight-PDT has the potential to facilitate treatment procedure and to reduce associated pain due to continuous activation of small amounts of porphyrins. Moreover, a reduced methyl aminolaevulinate (MAL) concentration may reduce associated inflammation, making the treatment more tolerable for the patients. To compare response rates and adverse effects after PDT using conventional 16% and 8% MAL with home-based daylight exposure in treatment of AK. Thirty patients with mostly thin-grade AK of the face or scalp were treated with 16% and 8% MAL-PDT in two symmetrical areas after application of sunscreen. Immediately after, patients left the hospital with instructions to spend the remaining day outside at home in daylight. Patients scored pain during treatment and light exposure was monitored with an electronic wristwatch dosimeter. The complete response rate after 3 months was 76.9% for 16% MAL and 79.5% for 8% MAL (P = 0.37). Patients spent a mean of 244 min outdoors and received a mean effective light dose of 30 J cm(-2). Light doses of 8-70 J cm(-2) induced similar response rates (P = 0.25). Patients experienced mild to moderate pain during daylight exposure (mean maximal pain score of 3.7). No differences in pain scores and erythema were seen between the areas treated with 16% MAL and with 8% MAL. Home-based daylight-mediated MAL-PDT was an effective and well-tolerated treatment for AK. No differences in response rates or adverse events were found between the areas treated with 16% MAL and with 8% MAL.Keywords
This publication has 12 references indexed in Scilit:
- Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded studyBritish Journal of Dermatology, 2008
- Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled studyBritish Journal of Dermatology, 2006
- Porphyrin Formation in Actinic Keratosis and Basal Cell Carcinoma after Topical Application of Methyl 5-AminolevulinateJournal of Investigative Dermatology, 2006
- Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trialBritish Journal of Dermatology, 2006
- Miniature Personal Electronic UVR Dosimeter with Erythema Response and Time‐stamped Readings in a WristwatchPhotochemistry and Photobiology, 2005
- Autofluorescence of Human Skin is Age-Related After Correction for Skin Pigmentation and RednessJournal of Investigative Dermatology, 2001
- 5-Aminolevulinic acid-based photodynamic therapyCancer, 1997
- Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acidInternational Journal of Cancer, 1997
- A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neckJournal of the American Academy of Dermatology, 1991
- MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMAThe Lancet, 1988